[Functional selectivity of opioid receptors ligands]
- PMID: 20819711
- DOI: 10.1051/medsci/2010268-9734
[Functional selectivity of opioid receptors ligands]
Abstract
Opiates are the most effective analgesics available for the treatment of severe pain. However, their clinical use is restricted by unwanted side effects such as tolerance, physical dependence and respiratory depression. The strategy to develop new opiates with reduced side effects has mainly focused on the study and production of ligands that specifically bind to different opiate receptors subtypes. However, this strategy has not allowed the production of novel therapeutic ligands with a better side effects profile. Thus, other research strategies need to be explored. One which is receiving increasing attention is the possibility of exploiting ligand ability to stabilize different receptor conformations with distinct signalling profiles. This newly described property, termed functional selectivity, provides a potential means of directing the stimulus generated by an activated receptor towards a specific cellular response. Here we summarize evidence supporting the existence of ligand-specific active conformations for two opioid receptors subtypes (delta and mu), and analyze how functional selectivity may contribute in the production of longer lasting, better tolerated opiate analgesics. double dagger.
Similar articles
-
Ligand-specific receptor states: implications for opiate receptor signalling and regulation.Cell Signal. 2007 Jan;19(1):8-19. doi: 10.1016/j.cellsig.2006.05.026. Epub 2006 Jun 7. Cell Signal. 2007. PMID: 16842969 Review.
-
A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5135-9. doi: 10.1073/pnas.0307601101. Epub 2004 Mar 24. Proc Natl Acad Sci U S A. 2004. PMID: 15044695 Free PMC article.
-
Attacking pain at its source: new perspectives on opioids.Nat Med. 2003 Aug;9(8):1003-8. doi: 10.1038/nm908. Nat Med. 2003. PMID: 12894165 Review.
-
In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.J Pharmacol Exp Ther. 2001 May;297(2):597-605. J Pharmacol Exp Ther. 2001. PMID: 11303048
-
Opioid pharmacology.Pain Physician. 2008 Mar;11(2 Suppl):S133-53. Pain Physician. 2008. PMID: 18443637 Review.
Cited by
-
Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses.Mol Pharmacol. 2014 Jan;85(1):148-61. doi: 10.1124/mol.113.089003. Epub 2013 Oct 30. Mol Pharmacol. 2014. PMID: 24174495 Free PMC article.
-
Heteroatom analogues of hydrocodone: synthesis and biological activity.J Org Chem. 2013 Apr 5;78(7):2914-25. doi: 10.1021/jo3026753. Epub 2013 Mar 6. J Org Chem. 2013. PMID: 23397939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials